TP53 and hepatocellular carcinoma: This suggests that metabolic characteristics may be associated with the genetic mutation profile, consistent with a previous report of HCC transcriptome classification demonstrating the associations between TP53 mutation and the cell cycle as well as those between CTNNB1 mutation and the Wnt pathway (45).